The Lancet Haematology

1. Giving von Willebrand disease the attention it deserves

   Publication date: March 2021

   Source: The Lancet Haematology, Volume 8, Issue 3

   Author(s): The Lancet Haematology

2. Paraneoplastic polyarteritis nodosa in a patient with cutaneous T-cell lymphoma

   Publication date: March 2021

   Source: The Lancet Haematology, Volume 8, Issue 3

   Author(s): Inès Chircop, Amélie Boespflug, Antoine Cini, Jean Christophe Lega, Stéphane Dalle

3. Chimeric antigen receptor T-cell therapy for the treatment of lymphoid malignancies: is there an excess risk for infection?

   Publication date: March 2021

   Source: The Lancet Haematology, Volume 8, Issue 3

   Author(s): Carlota Gudiol, Russell E Lewis, Paolo Strati, Dimitrios P Kontoyiannis

4. Development and validation of a disease risk stratification system for patients with haematological malignancies: a retrospective cohort study of the European Society for Blood and Marrow Transplantation registry

   Publication date: March 2021

   Source: The Lancet Haematology, Volume 8, Issue 3

   Author(s): Roni Shouval, Joshua A Fein, Myriam Labopin, Christina Cho, Ali Bazarbachi, Frédéric Baron, Gesine Bug, Fabio Ciceri, Selim Corbacioglu, Jacques-Emmanuel Galimard, Sebastian Giebel, Maria H Gilleece, Sergio Giralt, Ann Jakubowski, Silvia Montoto, Richard J O'Reilly, Esperanza B Papadopoulos, Zinaida Peric, Annalisa Ruggeri, Jaime Sanz

5. Proposed global prognostic score for systemic mastocytosis: a retrospective prognostic modelling study

   Publication date: March 2021

   Source: The Lancet Haematology, Volume 8, Issue 3

   Author(s): Javier I Muñoz-González, Iván Álvarez-Twose, María Jara-Acevedo, Roberta Zanotti, Cecelia Perkins, Mohamad Jawhar, Wolfgang R Sperr, Khalid Shoumariyeh, Juliana Schwaab, Georg Greiner, Ana Henriques, Carolina Caldas, Carlos Fernández-Giménez, Laura Sánchez-Muñoz, Andrea Mayado, Alba Pérez-Pons, Annette Schmitt-Graeff, Justus Duyster, Ilaria Tanasi, Francesco Olivieri

6. Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study

   Publication date: March 2021

   Source: The Lancet Haematology, Volume 8, Issue 3

   Author(s): Akshay Sharma, Neel S Bhatt, Andrew St Martin, Muhammad Bilal Abid, Jenni Bloomquist, Roy F Chemaly, Christopher Dandoy, Jordan Gauthier, Lohith Gowda, Miguel-Angel Perales, Stuart Seropian, Bronwen E Shaw, Eileen E Tuschl, Amer M Zeidan, Marcie L Riches, Gunjan L Shah

7. Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial

   Publication date: March 2021

   Source: The Lancet Haematology, Volume 8, Issue 3

   Author(s): Tiziano Barbui, Alessandro Maria Vannucchi, Valerio De Stefano, Arianna Masciulli, Alessandra Carobbio, Alberto Ferrari, Arianna Ghirardi, Elena Rossi, Fabio Ciceri, Massimiliano Bonifacio, Alessandra Iurlo, Francesca Palandri, Giulia Benevolo, Fabrizio Pane, Alessandra Ricco, Giuseppe Carli, Marianna Caramella, Davide Rapezzi, Caterina Musolino, Sergio Siragusa

8. Correction to Lancet Haematol 2021; 8: e175–84

   Publication date: March 2021

   Source: The Lancet Haematology, Volume 8, Issue 3

   Author(s):

9. Allogeneic haematopoietic stem cell transplantation from SARS-CoV-2 positive donors

   Publication date: March 2021

   Source: The Lancet Haematology, Volume 8, Issue 3

   Author(s): Mathieu Leclerc, Slim Fourati, Dehbia Menouche, Dominique Challine, Sébastien Maury

10. Risk stratification systems for allogeneic haematopoietic stem-cell transplantation

    Publication date: March 2021

    Source: The Lancet Haematology, Volume 8, Issue 3

    Author(s): Thomas Pabst, Ulrike Bacher

11. Improving prognostication and management of systemic mastocytosis

    Publication date: March 2021

    Source: The Lancet Haematology, Volume 8, Issue 3

    Author(s): Simona Soverini

12. A rationale to prioritise vaccination of HSCT patients against COVID-19

    Publication date: March 2021

    Source: The Lancet Haematology, Volume 8, Issue 3

    Author(s): Mathieu Leclerc, Sébastien Maury

13. Is it time for interferon in low-risk patients with polycythaemia vera?

    Publication date: March 2021

    Source: The Lancet Haematology, Volume 8, Issue 3

    Author(s): Sonja Heibl

14. Immune cytopenia after allogeneic haematopoietic stem-cell transplantation: challenges, approaches, and future directions

    Publication date: March 2021

    Source: The Lancet Haematology, Volume 8, Issue 3

    Author(s): Katharina Baur, Andreas S Buser, Laura Infanti, Jörg P Halter, Jakob R Passweg, Andreas Holbro

15. The changing face of haemophilia care in Pakistan

    Publication date: Available online 26 February 2021

    Source: The Lancet Haematology

    Author(s): Rabbia Tariq, Ariba Moin, Sarush Siddiqui

16. Ublituximab plus ibrutinib versus ibrutinib alone for patients with relapsed or refractory high-risk chronic lymphocytic leukaemia (GENUINE): a phase 3, multicentre, open-label, randomised trial

    Publication date: Available online 22 February 2021

    Source: The Lancet Haematology

    Author(s): Jeff P Sharman, Danielle M Brander, Anthony R Mato, Nilanjan Ghosh, Stephen J Schuster, Suman Kambhampati, John M Burke, Frederick Lansigan, Marshall T Schreeder, Scott D Lunin, Alexander Zweibach, Mikhail Shtivelband, Patrick M Travis, Jason C Chandler, Kathryn S Kolibaba, Peter Sportelli, Hari P Miskin, Michael S Weiss, Ian W Flinn

17. Myelodysplastic syndrome and acute myeloid leukaemia in patients treated with PARP inhibitors: a safety meta-analysis of randomised controlled trials and a retrospective study of the WHO pharmacovigilance database

    Publication date: February 2021

    Source: The Lancet Haematology, Volume 8, Issue 2

    Author(s): Pierre-Marie Morice, Alexandra Leary, Charles Dolladille, Basile Chrétien, Laurent Poulain, Antonio González-Martín, Kathleen Moore, Eileen Mary O'Reilly, Isabelle Ray-Coquard, Joachim Alexandre

18. MATRix–RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trial

    Publication date: February 2021

    Source: The Lancet Haematology, Volume 8, Issue 2

    Author(s): Andrés J M Ferreri, Jeanette K Doorduijn, Alessandro Re, Maria Giuseppina Cabras, Jeffery Smith, Fiorella Ilariucci, Mario Luppi, Teresa Calimeri, Chiara Cattaneo, Jahanzaib Khwaja, Barbara Botto, Claudia Cellini, Luca Nassi, Kim Linton, Pam McKay, Jacopo Olivieri, Caterina Patti, Francesca Re, Alessandro Fanni, Vikram Singh

19. Correction to Lancet Haematol 2021; 8: e122–34

    Publication date: February 2021

    Source: The Lancet Haematology, Volume 8, Issue 2

    Author(s):

20. Eradicating residual chronic myeloid leukaemia: basic research lost in translation

    Publication date: February 2021

    Source: The Lancet Haematology, Volume 8, Issue 2

    Author(s): Helong Zhao, Michael Deininger

21. Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study

    Publication date: February 2021

    Source: The Lancet Haematology, Volume 8, Issue 2

    Author(s): Lisa Pleyer, Michael Leisch, Alexandra Kourakli, Eric Padron, Jaroslaw Pawel Maciejewski, Blanca Xicoy Cirici, Jennifer Kaivers, Johanna Ungerstedt, Sonja Heibl, Peristera Patiou, Anthony Michael Hunter, Elvira Mora, Klaus Geissler, Maria Dimou, Maria-José Jimenez Lorenzo, Thomas Melchardt, Alexander Egle, Athina-Nora Viniou, Bhumika Jayantibhai Patel, Montserrat Arnan

22. PARP inhibitors—understanding the risk of myelodysplastic syndrome and acute myeloid leukaemia

    Publication date: February 2021

    Source: The Lancet Haematology, Volume 8, Issue 2

    Author(s): Anna V Tinker

23. The best matrix for the brain: advances in secondary CNS lymphoma

    Publication date: February 2021

    Source: The Lancet Haematology, Volume 8, Issue 2

    Author(s): Jorg Dietrich

24. COVID-19 vaccination in haematology services

    Publication date: February 2021

    Source: The Lancet Haematology, Volume 8, Issue 2

    Author(s): The Lancet Haematology

25. COVID-19 and thrombosis: a continuing story

    Publication date: February 2021

    Source: The Lancet Haematology, Volume 8, Issue 2

    Author(s): The Lancet Haematology

26. Preservation of fertility in teenagers and young adults treated for haematological malignancies

    Publication date: February 2021

    Source: The Lancet Haematology, Volume 8, Issue 2

    Author(s): Ephia Yasmin, Rod Mitchell, Sheila Lane

27. First-line hypomethylating agents for patients with high risk chronic myelomonocytic leukaemia

    Publication date: February 2021

    Source: The Lancet Haematology, Volume 8, Issue 2

    Author(s): Nelli Bejanyan, Claudio Anasetti